Vivus and Arena: A Tale of Dueling FDA Panel Minutes
Vivus and Arena: A Tale of Dueling FDA Panel Minutes TheStreet.com
View ArticleVivus Shares Set To Gain From Qnexa Despite Vulnerability
Vivus Shares Set To Gain From Qnexa Despite Vulnerability Yahoo/Reuters
View ArticleVivus Set To Benefit Despite Vulnerability
Vivus Set To Benefit Despite Vulnerability Seeking Alpha
View ArticleWhy Biotechs Arena And Vivus Will Grow While People Shrink
Why Biotechs Arena And Vivus Will Grow While People Shrink Seeking Alpha
View ArticleVivus, Onyx, Amarin Await Key Dates in July
Vivus, Onyx, Amarin Await Key Dates in July Minyanville
View ArticleInsider Sales at Vivus: Sign of Things to Come?
Insider Sales at Vivus: Sign of Things to Come? Motley Fool
View ArticleVivus Insiders Sell Stock Ahead of Crucial FDA Approval Decision
Vivus Insiders Sell Stock Ahead of Crucial FDA Approval Decision TheStreet.com
View ArticleWhy Hedge Funds Prefer Vivus Over Arena
Why Hedge Funds Prefer Vivus Over Arena Seeking Alpha
View ArticleVivus: A New Twist On The Qnexa Story
Vivus: A New Twist On The Qnexa Story Seeking Alpha
View ArticleLingering Concerns about Qnexa's Safety
Lingering Concerns about Qnexa's Safety Motley Fool
View ArticleCan Vivus Follow Arena’s Victory in 5 Days?
Can Vivus Follow Arena’s Victory in 5 Days? Wall St. Cheat Sheet
View ArticleWill the FDA Approve VIVUS' Obesity Drug?
Will the FDA Approve VIVUS' Obesity Drug? Motley Fool
View ArticlePartnership and Acquisition in the Red Hot Weight Loss Market
Partnership and Acquisition in the Red Hot Weight Loss Market Motley Fool
View ArticleVivus, Orexigen climb ahead of FDA decision
Vivus, Orexigen climb ahead of FDA decision Marketwatch
View ArticleDiet drug makers Vivus and Orexigen fall ahead of FDA decision
Diet drug makers Vivus and Orexigen fall ahead of FDA decision Reuters
View ArticleVivus Weight-Loss Pill Approved -- Maybe?
Vivus Weight-Loss Pill Approved -- Maybe? TheStreet.com
View ArticleU.S. FDA approves Vivus weight-loss pill Qsymia
U.S. FDA approves Vivus weight-loss pill Qsymia Reuters
View ArticleVivus Stock Jumps 12.5% On Drug Approval
Vivus Stock Jumps 12.5% On Drug Approval Investors.com
View ArticleQnexa (Now Qsymia) Granted FDA Approval, Now What?
Qnexa (Now Qsymia) Granted FDA Approval, Now What? Seeking Alpha
View Article